We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

3cg2

From Proteopedia

(Difference between revisions)
Jump to: navigation, search

OCA (Talk | contribs)
(New page: 200px <!-- The line below this paragraph, containing "STRUCTURE_3cg2", creates the "Structure Box" on the page. You may change the PDB parameter (which sets the PD...)
Next diff →

Revision as of 11:26, 9 April 2008

Template:STRUCTURE 3cg2

P38 Alpha Kinase complexed with a Pyrazolo-Pyrimidine based inhibitor


Overview

The synthesis and structure-activity relationships (SAR) of p38alpha MAP kinase inhibitors based on a pyrazolo-pyrimidine scaffold are described. These studies led to the identification of compound 2x as a potent and selective inhibitor of p38alpha MAP kinase with excellent cellular potency toward the inhibition of TNFalpha production. Compound 2x was highly efficacious in vivo in inhibiting TNFalpha production in an acute murine model of TNFalpha production. X-ray co-crystallography of a pyrazolo-pyrimidine analog 2b bound to unphosphorylated p38alpha is also disclosed.

About this Structure

3CG2 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Pyrazolo-pyrimidines: A novel heterocyclic scaffold for potent and selective p38alpha inhibitors., Das J, Moquin RV, Pitt S, Zhang R, Shen DR, McIntyre KW, Gillooly K, Doweyko AM, Sack JS, Zhang H, Kiefer SE, Kish K, McKinnon M, Barrish JC, Dodd JH, Schieven GL, Leftheris K, Bioorg Med Chem Lett. 2008 Mar 10;. PMID:18359226

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools